Strong validation of Evaxion’s AI-Immunology™ platform in multiple clinical trials Data from three separate clinical trials documents the strong ability of the AI-Immunology™ platform to select clinically relevant vaccine targets Strongest outcomes are generated by the top-ranked...

Evaxion launches improved AI-Immunology™ platform for vaccine antigen prediction The new version 5.0 of the AI model EDEN™ features a novel toxin antigen predictor, is trained on an expanded dataset and includes an advanced protein prediction featureThe launch will expectedly...

Evaxion Showcases Improved Performance of Key Building Block in AI-Immunology™ at Computational Biology Conference Central AI-Immunology™ Building Block: Evaxion’s proprietary in-house developed building block, EvaxMHC, is used across the AI-Immunology™ platform Improved Performance: Utilizing a state-of-the-art...

WINGS Announces Beta Testnet Launch to Evaluate ICOs with Crowdsourced Due Diligence ZUG, Switzerland, Dec. 30, 2017 (GLOBE NEWSWIRE) -- WINGS (www.wings.ai) today announced the upcoming Beta Testnet launch of its Ethereum-based platform for evaluating ICOs with crowdsourced due...

PredictionCX Uses Big Data to Predict Customer Actions, Now Available from MaritzCX SALT LAKE CITY, June 30, 2016 (GLOBE NEWSWIRE) -- MaritzCX, a global customer experience (CX) software and services company, today announced the availability of PredictionCX™, the...